pI: 5.5355 |
Length (AA): 628 |
MW (Da): 67548 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 620 | 5a9v (A) | 4 | 600 | 47.00 | 0 | 1 | 1.37557 | 0.53 |
5 | 150 | 4ac9 (C) | 7 | 146 | 31.00 | 0.0000005 | 1 | 0.498784 | -0.27 |
322 | 618 | 3e3x (A) | 26 | 324 | 47.00 | 0 | 1 | 0.96123 | 0.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128930)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G13650 | putative TypA-like translation elongation factor SVR3 |
Arabidopsis thaliana | AT2G31060 | elongation factor family protein |
Babesia bovis | BBOV_IV007720 | GTP binding protein, putative |
Dictyostelium discoideum | DDB_G0276121 | hypothetical protein |
Escherichia coli | b3871 | GTP-binding protein |
Leishmania braziliensis | LbrM.25.0130 | elongation factor, putative |
Leishmania donovani | LdBPK_250130.1 | elongation factor, putative |
Leishmania infantum | LinJ.25.0130 | elongation factor, putative |
Leishmania major | LmjF.25.0130 | elongation factor, putative |
Leishmania mexicana | LmxM.25.0130 | elongation factor, putative |
Mycobacterium leprae | ML1498c | POSSIBLE GTP-BINDING TRANSLATION ELONGATION FACTOR TYPA (TYROSINE PHOSPHORYLATED PROTEIN A) (GTP-BINDING PROTEIN) |
Mycobacterium tuberculosis | Rv1165 | Possible GTP-binding translation elongation factor TypA (tyrosine phosphorylated protein A) (GTP-binding protein) |
Mycobacterium ulcerans | MUL_1009 | GTP-binding translation elongation factor TypA |
Neospora caninum | NCLIV_012820 | GTP-binding protein TypA, related |
Oryza sativa | 4327008 | Os01g0752700 |
Oryza sativa | 4329037 | Os02g0285800 |
Plasmodium berghei | PBANKA_1421900 | GTP-binding translation elongation factor, putative |
Plasmodium falciparum | PF3D7_0715600 | GTP-binding translation elongation factor tu family protein, putative |
Plasmodium knowlesi | PKNH_1424600 | GTP-binding translation elongation factor tu family protein, putative |
Plasmodium vivax | PVX_122985 | GTP-binding protein TypA, putative |
Plasmodium yoelii | PY02880 | elongation factor Tu family protein-related |
Schmidtea mediterranea | mk4.047253.02 | |
Trypanosoma brucei gambiense | Tbg972.11.60 | elongation factor, putative |
Trypanosoma brucei | Tb427tmp.03.0940 | elongation factor, putative |
Trypanosoma brucei | Tb927.11.190 | elongation factor, putative |
Trypanosoma cruzi | TcCLB.504109.150 | elongation factor, putative |
Toxoplasma gondii | TGME49_301380 | elongation factor Tu GTP binding domain-containing protein |
Theileria parva | TP03_0279 | GTP-binding elongation factor, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0061 | stress response membrane GTPase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.03.0940 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0940 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0940 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.03.0940 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3871 | Escherichia coli | non-essential | goodall |
PBANKA_1421900 | Plasmodium berghei | Essential | plasmo |
TGME49_301380 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.